Study of the Efficacy and Safety of AMT-101 in Combination With Adalimumab in Subjects With Ulcerative Colitis (MARKET) - NCT05372939

Ulcerative Colitis disease activity as assessed by mean change in UC-100 Score from baseline, Mean change in Robarts Histopathology Index (RHI) from baseline, Mean change in total Mayo Clinic Score (MCS) and component scores (Mayo Endoscopic Subscore [MES], partial MCS, rectal bleeding and stool frequency) from baseline, (and 5 more...)